KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic ResistanceKunihiko Hinohara, Kornélia Polyák, Madhu Lal‐Nag et al.|Cancer Cell|2018Cited by 255
JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E. Stevens, Kornélia Polyák, Guillermo Peluffo et al.|Cancer Research|2022Cited by 101
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3Marco Seehawer, Kornélia Polyák, Zheqi Li et al.|Nature Cell Biology|2024Cited by 45
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic ResistanceKunihiko Hinohara, Kornélia Polyák, Hua‐Jun Wu et al.|Cancer Cell|2019Cited by 42
KDM5ヒストンデメチラーゼ活性は細胞トランスクリプトームの不均一性を治療抵抗性に関連付ける【JST・京大機械翻訳】Hinohara Kunihiko, Kornélia Polyák, Wu Hua-Jun et al.|Cancer Cell|2018Cited by 39